MedTech Acquisition - Warrants (18/12/2025) Current Cash

The latest current cash for MTACW is $46M as of June 2026. That compares with $26M in the prior-year period — up 74.7% year over year. Investors often review this figure alongside MedTech Acquisition - Warrants (18/12/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, MTACW's current cash moved from $26M to $46M — a 74.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MedTech Acquisition - Warrants (18/12/2025)'s operating scale or balance-sheet position.

A current cash figure of $46M for MTACW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MTACW's current cash ($46M), review year-over-year change from $26M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.